Last Updated:
Bangladesh Allows Emergency Use Of Chinese Vaccine Amidst Delay From India’s SII
Bangladesh on Thursday approved the emergency use of China s Sinopharm COVID-19 vaccine, two days after allowing Russia s Sputnik amidst concern over the availability of the Oxford-AstraZeneca vaccine produced by the Serum Institute of India.
Image Credits: AP
Bangladesh on Thursday approved the emergency use of China s Sinopharm COVID-19 vaccine, two days after allowing Russia s Sputnik amidst concern over the availability of the Oxford-AstraZeneca vaccine produced by the Serum Institute of India. The development came as health officials reported 88 deaths in the country due to the coronavirus in one day, taking the total number of fatalities to 11,393.
Coronavirus | Bangladesh allows emergency use of Chinese vaccine amidst delay from India’s SII
Updated:
Updated:
April 29, 2021 19:07 IST
‘The Chinese vaccine would be procured through the government-to government agreement while talks were also underway on manufacturing Sinopharm in Bangladesh itself’
Share Article
File photo of China Sinopharm coronavirus vaccine. | Photo Credit: AP
‘The Chinese vaccine would be procured through the government-to government agreement while talks were also underway on manufacturing Sinopharm in Bangladesh itself’ Bangladesh on Thursday approved the emergency use of China s Sinopharm COVID-19 vaccine, two days after allowing Russia s Sputnik amidst concern over the availability of the Oxford-AstraZeneca vaccine produced by the Serum Institute of India.